JAPM in collaboration with JFDA & USP, announces the opening of Registration in: “Biosimilars Workshop" Speakers: JFDA & USP Who should attend: Quality Managers and Authorised Person(s) Quality Control Managers Operations Managers RA Managers GMP Team Leaders R&D Team Leaders Department Heads @ Pharmaceutical Companies For registration & more information email: dana@japm.com or call JAPM offices on +962 6 5413114

JAPM with the support of IFC Announces the opening of Registration for Two Virtual Workshops: “Computer System Validation Workshop” & “Process Validation workshop” Registration is open for one or both Who should attend: Quality managers and personnel responsible for reviewing validation Quality personnel involved in the management of ongoing process verification programs Validation personnel at all levels Operational staff with responsibility for executing validation Employees who design, validate or administer GMP computerised systems End users of GMP computerised systems with involvement in the validation process Validation staff with limited or no computerised systems experience, looking to widen their knowledge @

JAPM with the support of IFC Announces the opening of Registration for the Virtual Workshop: “Fundamentals of Biological Drugs Workshop” Who should attend: Quality Managers and Authorised Person(s) Quality Control Managers Operations Managers RA Managers GMP Team Leaders R&D Team Leaders Department Heads @ Pharmaceutical Companies “Fundamentals of Biological Drugs workshop” will help you to understand: Upon completion of this Fundamentals for Biological Drugs training course participants will understand. What is a Biologically Derived Drug and how does it differ from a synthetic drug? PIC/S clauses and Annexes that refer to such products Differences between WHO and PIC/s for biological

Book your seat in a two-day workshop: "How to Conduct Patent Searches as a Generic Company Workshop" Limited seats & please confirm your registration not later than March 7th. Dates: March 15th & 16th , 2022 Speaker: Dr. Farida Alayan Intellectual property manager / Axantia ( PIC –Jordan & Med city –KSA). Topics: Introduction to patents, patent system and patent information Types of pharmaceutical patents How to search for patents on pharmaceutical products in Jordan & in the region. Freedom to operate (FTO) Updates on pharmaceutical patents in the region Who Should Attend: Regulatory Affairs Professionals R&D Professionals IP practitioners

JAPM with the support of JFDA & IFC Announces the opening of Registration for the Virtual Workshop: “Risk Management” Risk management and prevention of cross contamination training course Manufacturers of medicinal products must ensure they do not place patients at risk due to inadequate safety, quality or efficacy. To achieve this goal, it is a GMP requirement that appropriate attention is paid to those factors that present cross-contamination risks. This course is designed to help you identify the cross-contamination risks in your facility, identify appropriate risk controls which are designed on the basis of the hazard presented by the materials

JAPM with the support of JFDA & IFC Announces the opening of Registration for the Virtual Workshop: Data Integrity Workshop Data Integrity Training Course Data integrity is not new. It is implicit, and always has been, as a foundation of good manufacturing practice (GMP). The subject of data integrity, however, has an increased profile because hybrid (paper and electronic), digital technologies and electronic systems have become prevalent in modern manufacturing. Globally regulators are recruiting and training their Regulatory Compliance Inspectors in data integrity. During GMP compliance audits, Inspectors are identifying increasing numbers of GMP violations linked to data integrity. The

To discuss in detail the implementation of the newly issued JFDA Annual Report Guidelines JAPM in cooperation with JFDA Announces the opening of the Registration in the: “Annual Report Workshop” Provided by JFDA Drug Registration Team Who should attend: Quality Assurance, Quality Control Technical Managers Quality & Compliance Regulatory Affairs Staff @ Pharmaceutical Companies For registration & more information email: dana@japm.com or call JAPM offices on +962 6 5413114 Attention: in order to attend the workshop, you should fit in one of the below categories as we strictly apply the government rules in this regard: Be fully vaccinated against COVID-19

In-Person workshops are back ! JAPM announces the opening of Registration in: Validation Requirements & Evaluation Workshop Provided by JFDA Validation Committee and JFDA QC Lab Team Targeted Audience: R&D personnel at pharmaceutical manufacturers “The workshop will be repeated in two dates. To comply with the National Defense Law in Jordan; we will accept the registration of a limited number of participants according to the capacity limit of the venue; kindly register in the one of the below dates” Monday: June 28th , 2021 or Monday: July 5th, 2021 Venue: Rotana Hotel- Amman For registration & more information email: dana@japm.com

JFDA, IFC, JAPM Announce the opening of registration for the: "PIC/S Inspection Procedures & Inspection techniques from the Industry's point of view” Workshop Who should attend: Quality Assurance, Quality Control, Technical Managers, Quality & Compliance Regulatory Affairs staff @ Pharmaceutical Companies For registration & more information please email: dana@japm.com

JAPM with the support of JFDA & IFC Announces the opening of Registration for the Virtual Workshop: “Remote Auditing Workshop” Who should attend: Quality Assurance, Quality Control Technical Managers Quality & Compliance Regulatory Affairs Staff @ Pharmaceutical Companies Questions this “Remote Auditing Techniques Workshop” helps answer: What do Auditee needs to know to prepare & get ready for a remote audit? What do Internal Auditors need to know in order to conduct a Remote Audit on their suppliers successfully? What are the benefits of conducting remote audits vs onsite inspections during a global pandemic, when onsite auditing is risky to